APOE ε4 and cognitive dysfunction in multiple sclerosis: A review

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 22, Issue 2, 2010, Pages 155-165

  Ghaffar, Omar ^a   Feinstein, Anthony ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CHOLINE; CREATINE; CREATININE; INTERFERON BETA SERINE; N ACETYLASPARTIC ACID;

ALLELE; ASTROCYTE; BRAIN ATROPHY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FOLLOW UP; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC DATABASE; GENOTYPE; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MENTAL TEST; METHODOLOGY; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PATHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAPSE; REVIEW; RISK; SAMPLE SIZE; TISSUE INJURY; BRAIN; GENETICS;

APOLIPOPROTEIN E4; BRAIN; COGNITION DISORDERS; HUMANS; MULTIPLE SCLEROSIS;

EID: 85047684775     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2010.22.2.155     Document Type: Review

References (102)

1. Rao SM, Leo GJ, Bernardin L, et al: Cognitive dysfunction in multiple sclerosis, I: frequency, patterns, and prediction. Neurology 1991; 41:685-691
2. Rao SM, Leo GJ, Ellington L, et al: Cognitive dysfunction in multiple sclerosis, II: impact on employment and social functioning. Neurology 1991; 41:692-696
3. McIntosh-Michaelis SA, Roberts MH, Wilkinson SM, et al: The prevalence of cognitive impairment in a community survey of multiple sclerosis. Br J Clin Psychol 1991; 30(part 4):333-348
4. Chiaravalloti ND, DeLuca J: Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7:1139-1151
5. Patti F: Cognitive impairment in multiple sclerosis. Mult Scler 2009; 15:2-8
6. Amato MP, Zipoli V, Portaccio E: Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 2006; 245:41-46 (Pubitemid 43775956)
7. Foong J, Rozewicz L, Chong WK, et al: A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J Neurol 2000; 247:97-101 (Pubitemid 30162522)
8. Amato MP, Zipoli V, Goretti B, et al: Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006; 253:1054-1059 (Pubitemid 44441131)
9. Marsh GG: Disability and intellectual function in multiple sclerosis patients. J Nerv Ment Dis 1980; 168:758-762 (Pubitemid 11209780)
10. Rao SM, Glatt S, Hammeke TA, et al: Chronic progressive multiple sclerosis relationship between cerebral ventricular size and neuropsychological impairment. Arch Neurol 1985; 42:678-682 (Pubitemid 15062824)
11. Wishart HA, Flashman L, Saykin AJ: The neuropsychology of multiple sclerosis: contributions of neuroimaging research. Curr Psychiatry Rep 2001; 3:373-378
12. Tartaglia MC, Arnold DL: The role of MRS and fMRI in multiple sclerosis. Adv Neurol 2006; 98:185-202
13. Rovaris M, Comi G, Filippi M: MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 2006; 245:111-116 (Pubitemid 43775933)
14. Mainero C, Pantano P, Caramia F, et al: Brain reorganization during attention and memory tasks in multiple sclerosis: insights from functional MRI studies. J Neurol Sci 2006; 245:93-98 (Pubitemid 44218704)
15. Dineen RA, Vilisaar J, Hlinka J, et al: Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009; 132:239-249
16. Bonzano L, Pardini M, Mancardi GL, et al: Structural connectivity influences brain activation during PVSAT in multiple sclerosis. Neuroimage 2009; 44:9-15
17. Mesaros S, Rovaris M, Pagani E, et al: A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008; 65:1223-1230
18. Sicotte NL, Kern KC, Giesser BS, et al: Regional hippocampal atrophy in multiple sclerosis. Brain 2008; 131:1134-1141 (Pubitemid 351499428)
19. Warlop NP, Achten E, Debruyne J, Vingerhoets G: Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosis. Neuropsychologia 2008; 46:2258-2264
20. Houtchens MK, Benedict RH, Killiany R, et al: Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007; 69:1213-1223
21. Amato MP, Portaccio E, Goretti B, et al: Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol 2007; 64:1157-1161 (Pubitemid 47258075)
22. Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, et al: Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007; 36:1294-1300 (Pubitemid 47007715)
23. Mahley RW, Rall SC Jr: Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1:507-537
24. Zhong N, Weisgraber KH: Understanding the association of apolipoprotein E4 with Alzheimer's disease: clues from its structure. J Biol Chem 2009; 284:6027-6031
25. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-923
26. Weisgraber KH, Mahley RW: Human apolipoprotein E: the Alzheimer's disease connection. FASEB J 1996; 10:1485-1494 (Pubitemid 26384445)
27. Ashford JW, Mortimer JA: Non-familial Alzheimer's disease is mainly due to genetic factors. J Alzheimers Dis 2002; 4:169-177 (Pubitemid 35006049)
28. Raber J, Huang Y, Ashford JW: APOE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25:641-650 (Pubitemid 38686487)
29. Cherbuin N, Leach LS, Christensen H, et al: Neuroimaging and APOE genotype: a systematic qualitative review. Dement Geriatr Cogn Disord 2007; 24:348-362 (Pubitemid 350036691)
30. Filippini N, Rao A, Wetten S, et al: Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Neuroimage 2009; 44:724-728
31. Smith GE, Bohac DL, Waring SC, et al: Apolipoprotein E genotype influences cognitive phenotype in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998; 50:355-362 (Pubitemid 28119770)
32. Deary IJ, Whiteman MC, Pattie A, et al: Cognitive change and the APOE epsilon 4 allele. Nature 2002; 418:932 (Pubitemid 34976020)
33. Small BJ, Rosnick CB, Fratiglioni L, et al: Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19:592-600
34. Flory JD, Manuck SB, Ferrell RE, et al: Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet 2000; 96:707-711
35. Bartzokis G, Lu PH, Geschwind DH, et al: Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 2006; 63:63-72 (Pubitemid 43037470)
36. Wishart HA, Saykin AJ, McAllister TW, et al: Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006; 67:1221-1224 (Pubitemid 44563831)
37. Chen K, Reiman EM, Alexander GE, et al: Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Am J Psychiatry 2007; 164:916-921 (Pubitemid 46972907)
38. Burggren AC, Zeineh MM, Ekstrom AD, et al: Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 2008; 41:1177-1183
39. Nilsson LG, Nyberg L, Backman L: Genetic variation in memory functioning. Neurosci Biobehav Rev 2002; 26:841-848
40. Savitz J, Solms M, Ramesar R: Apolipoprotein E variants and cognition in healthy individuals: a critical opinion. Brain Res Rev 2006; 51:125-135 (Pubitemid 43782534)
41. Jiang Q, Lee CY, Mandrekar S, et al: APOE promotes the proteolytic degradation of Abeta. Neuron 2008; 58:681-693 (Pubitemid 351778466)
42. Poirier J: Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease. Alzheimers Dement 2008; 4:S91-97
43. Tukhovskaya EA, Yukin AY, Khokhlova ON, et al: COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia. J Neurosci Res 2009; 87:677-682
44. Tzourio C, Arima H, Harrap S, et al: APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology 2008; 70:1322-1328 (Pubitemid 351550353)
45. Hopkins RO, Weaver LK, Valentine KJ, et al: Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. Am J Respir Crit Care Med 2007; 176:1001-1006
46. Rao R, Tah V, Casas JP, et al: Ischemic stroke subtypes and their genetic basis: a comprehensive meta-analysis of small and large vessel stroke. Eur Neurol 2009; 61:76-86
47. Lane R, He Y, Morris C, et al: BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Mov Disord 2009; 24:392-400
48. Ezquerra M, Campdelacreu J, Gaig C, et al: Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease. Neurosci Lett 2008; 448:20-23
49. Zetterberg H, Jacobsson J, Rosengren L, et al: Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis. J Neurol Sci 2008; 273:67-69
50. Allen NC, Bagade S, McQueen MB, et al: Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008; 40:827-834 (Pubitemid 351913655)
51. Zhou W, Xu D, Peng X, et al: Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma 2008; 25:279-290 (Pubitemid 351457767)
52. Burwick RM, Ramsay PP, Haines JL, et al: APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology 2006; 66:1373-1383
53. Pinholt M, Frederiksen JL, Christiansen M: The association between apolipoprotein E and multiple sclerosis. Eur J Neurol 2006; 13:573-580
54. Oliveri RL, Cittadella R, Sibilia G, et al: APOE and risk of cognitive impairment in multiple sclerosis. Acta Neurol Scand 1999; 100:290-295 (Pubitemid 29482551)
55. Parmenter BA, Denney DR, Lynch SG, et al: Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms. Mult Scler 2007; 13:25-32
56. Savettieri G, Messina D, Andreoli V, et al: Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 2004; 251:1208-1214 (Pubitemid 39517923)
57. Benedict RH, Cookfair D, Gavett R, et al: Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12:549-558 (Pubitemid 44070305)
58. Feinstein A: Cognitive impairment in multiple sclerosis, in The Clinical Neuropsychiatry of Multiple Sclerosis, 2nd ed. Feinstein A. New York, Cambridge University Press, 2007, pp 115-144
59. Koutsis G, Panas M, Giogkaraki E, et al: APOE epsilon4 is associated with impaired verbal learning in patients with MS. Neurology 2007; 68:546-549 (Pubitemid 46303599)
60. Rao SM, Cognitive Function Study Group of the National Multiple Sclerosis Society: A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee, Wi, Medical College of Wisconsin, 1990
61. Shi J, Zhao CB, Vollmer TL, et al: APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 2008; 70:185-190
62. Summers M, Fisniku L, Anderson V, et al: Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. Mult Scler 2008; 14:197-204 (Pubitemid 351639628)
63. Archibald CJ, Wei X, Scott JN, et al: Posterior fossa lesion volume and slowed information processing in multiple sclerosis. Brain 2004; 127:1526-1534 (Pubitemid 38899406)
64. Amato MP, Portaccio E, Goretti B, et al: Association of neocortical volume changes with cognitive deterioration in relapsing- remitting multiple sclerosis. Arch Neurol 2007; 64:1157-1161 (Pubitemid 47258075)
65. Houtchens MK, Benedict RH, Killiany R, et al: Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007; 69:1213-1223 (Pubitemid 47429021)
66. Brass SD, Benedict RH, Weinstock-Guttman B, et al: Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006; 12:437-444 (Pubitemid 44132584)
67. Hildebrandt H, Hahn HK, Kraus JA, et al: Memory performance in multiple sclerosis patients correlates with central brain atrophy. Mult Scler 2006; 12:428-436 (Pubitemid 44132583)
68. Sanfilipo MP, Benedict RH, Weinstock-Guttman B, et al: Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006; 66:685-692 (Pubitemid 43739822)
69. Benedict RH, Ramasamy D, Munschauer F, et al: Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009; 80:201-206
70. Mineev KK, Prakhova LN, Il'ves AG, et al: Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy. Neurosci Behav Physiol 2009; 39:35-38
71. Lin X, Tench CR, Morgan PS, Constantinescu CS: Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008; 79:437-441 (Pubitemid 351441502)
72. Rashid W, Miller DH: Recent advances in neuroimaging of multiple sclerosis. Semin Neurol 2008; 28:46-55 (Pubitemid 351273083)
73. Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, et al: Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007; 36:1294-1300 (Pubitemid 47007715)
74. Bermel RA, Bakshi R: The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5:158-170 (Pubitemid 43107851)
75. Ranjeva JP, Audoin B, Au Duong MV, et al: Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis. J Neurol Sci 2006; 245:161-167 (Pubitemid 43775936)
76. Rovaris M, Comi G, Filippi M: MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 2006; 245:111-116 (Pubitemid 43775933)
77. Lanzillo R, Prinster A, Scarano V, et al: Neuropsychological assessment, quantitative MRI and APOE gene polymorphisms in a series of MS patients treated with IFN beta-1b. J Neurol Sci 2006; 245:141-145 (Pubitemid 43775937)
78. Fazekas F, Strasser-Fuchs S, Schmidt H, et al: Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 69:25-28 (Pubitemid 30410410)
79. van Walderveen MA, Kamphorst W, Scheltens P, et al: Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50:1282-1288 (Pubitemid 28240340)
80. van Walderveen MA, Truyen L, van Oosten BW, et al: Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity. Arch Neurol 1999; 56:345-351 (Pubitemid 29120233)
81. van Walderveen MA, Barkhof F, Pouwels PJ, et al: Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 1999; 46:79-87 (Pubitemid 29314385)
82. Fisher E, Chang A, Fox RJ, et al: Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann Neurol 2007; 62:219-228 (Pubitemid 47525397)
83. Enzinger C, Ropele S, Strasser-Fuchs S, et al: Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele. Arch Neurol 2003; 60:65-70 (Pubitemid 36078110)
84. Enzinger C, Ropele S, Smith S, et al: Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4. Ann Neurol 2004; 55:563-569 (Pubitemid 38391974)
85. De Stefano N, Bartolozzi ML, Nacmias B, et al: Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. Arch Neurol 2004; 61:536-540 (Pubitemid 38923743)
86. Schreiber K, Otura AB, Ryder LP, et al: Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E). Mult Scler 2002; 8:295-298 (Pubitemid 34784756)
87. Zwemmer JN, van Veen T, van Winsen L, et al: No major association of APOE genotype with disease characteristics and MRI findings in multiple sclerosis. Mult Scler 2004; 10:272-277 (Pubitemid 38807453)
88. Zakrzewska-Pniewska B, Styczynska M, Podlecka A, et al: Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis. Mult Scler 2004; 10:266-271 (Pubitemid 38807452)
89. Parmenter BA, Weinstock-Guttman B, Garg N, et al: Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler 2007; 13:52-57 (Pubitemid 46152761)
90. Benedict RH, Cookfair D, Gavett R, et al: Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12:549-558 (Pubitemid 44070305)
91. Benedict RH, Fischer JS, Archibald CJ, et al: Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16:381-397 (Pubitemid 36390381)
92. Shaw P, Lerch JP, Pruessner JC, et al: Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007; 6:494-500 (Pubitemid 46734757)
93. Reiman EM, Uecker A, Caselli RJ, et al: Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998; 44:288-291 (Pubitemid 28374124)
94. Tohgi H, Takahashi S, Kato E, et al: Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett 1997; 236:21-24 (Pubitemid 27492069)
95. Plassman BL, Welsh-Bohmer KA, Bigler ED, et al: Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 1997; 48:985-989 (Pubitemid 27175626)
96. Schmidt H, Schmidt R, Fazekas F, et al: Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet 1996; 50:293-299 (Pubitemid 27019657)
97. Hildebrandt H, Hahn HK, Kraus JA, et al: Memory performance in multiple sclerosis patients correlates with central brain atrophy. Mult Scler 2006; 12:428-436 (Pubitemid 44132583)
98. Benedict RH, Weinstock-Guttman B, Fishman I, et al: Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61:226-230 (Pubitemid 38197556)
99. Sanchez MP, Nieto A, Barroso J, et al: Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis. Eur J Neurol 2008; 15:1091-1099
100. Benedict RH, Bruce JM, Dwyer MG, et al: Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006; 63:1301-1306
101. Sanfilipo MP, Benedict RH, Weinstock-Guttman B, et al: Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006; 66:685-692 (Pubitemid 43739822)
102. Bermel RA, Bakshi R: The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5:158-170 (Pubitemid 43107851)